Control Plasma Level 2

SECTION 2: Hazards identification

WHMIS 2015 Classification of the mixture

Hazard categories

Hazard statement Not classified For exposure limits see section 8 Potential adverse physicochemical, human health and environmental effects see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment

Hazard pictograms

none

Signal word

none

Hazard statements

none

Precautionary statements

none ≈ 98.7% of the mixture consists of component of unknown acute toxicity (oral, dermal, Other labeling details: inhalation) for the human health and unknown hazard to the aquatic environment. Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains.

Other hazards which do not result in classification

The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease.

2.1 Classification of the substance or mixture

This product is not hazardous according to Regulations (EC) No 1272/2008, OSHA 29 CFR 1910.1200 and Hazardous Product Regulation HPR (WHMIS 2015). Any additional information concerning the risks for health and/or the environment are given in sections 11 and 12 of this sheet. According to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015): Hazard class Hazard category Hazard statement Not classified For exposure limits see section 8. Potential adverse physicochemical, human health and environmental effects (see also Ch. 9-12) Under normal conditions of use, the mixture does not cause adverse effects to humans and to the environment. 2.2 Label elements, according to Regulation (EC) No 1272/2008, according to Hazard Communication Standard, 29 CFR 1910.1200 (HCS), and according to Hazardous Product Regulation HPR (WHMIS 2015): Hazard pictogram(s): none Signal word(s): none Hazard statement(s): none Precautionary statement(s): none ≈ 98.7% of the mixture consists of component of unknown acute toxicity (oral, dermal, Other labeling details: inhalation) for the human health and unknown hazard to the aquatic environment. Safety precautions: Use the product in accordance with the Good Laboratory Practice. Wear suitable protective clothing, gloves and eye/face protection. Do not let the product enter drainage system, surface and ground-water or soil. Do not empty into drains. 2.3 Other hazards (which do not results in the classification) The mixture does not meet the criteria for PBT or vPvB. Warning: This product contains human source material that tested non-reactive for HIV antibody, Hepatitis B Surface Antigen and Anti-HCV at the donor stage. This product, as with all human based specimens, should be handled with proper laboratory safety procedures to minimize the risk of transmission of infectious disease. SECTION 3. COMPOSITION/INFORMATION ON INGREDIENTS Composition: solid containing organic and inorganic components, human plasma. 3.1 Hazardous components: Classification Name EINECS/ CAS n° Conc. % 29 CFR 1910.1200 (HCS) Classification ELINCS n° w/w* HPR (WHMIS 2015) 1272/2008/EC Calcium chloride dihydrate 233-140-8 10035-04-8 < 0.01% Eye damage/irritation, cat. 2 Eye Irrit.2, H319 Index N. (Annex VI of CLP Reg.): (as Calcium (10043-52-4 017‐013‐00‐2 chloride as Calcium anhydrous) chloride anhydr.) Zinc chloride 231-592-0 7646-85-7 < 0.001% Acute Tox. – Oral, cat. 4 Acute Tox. 4, H302 Index N. (Annex VI of CLP Reg.): Skin Corrosion/Irritation, cat.1B Skin Corr. 1B, H314 030‐003‐00‐2